Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Title Grant Type Focus Area Country Application Due Date 2023 Inflammatory Bowel Disease (IBD) FellowshipRelease Date:Fellowship Inflammation & Immunology USA Advances in the Management of Ulcerative Colitis (UC)Release Date:Education Inflammation & Immunology USA Knowledge Gaps in Managing High-Risk Patients and COVID-19Release Date:Education Hospital USA 2023 Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for ProposalsRelease Date:Partner: Bladder Cancer Canada; EMD SeronoQuality Improvement Oncology Canada Relapsed/Refractory Multiple Myeloma (North America and Europe)Release Date:Education Oncology All Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity in Latin AmericaRelease Date:Partner: Conquer Cancer, the ASCO FoundationQuality Improvement Oncology All Junior Investigator Global ATTR Amyloidosis Research ASPIRE (All countries except for the United States)Release Date:Research Rare Disease All Call for Independent Medical Education Grant Applications Oncology – Prostate CancerEducation Oncology USA Improving the Care of Patients Living with Metastatic Breast Cancer (mBC)Release Date:Partner: Rethink Breast CancerQuality Improvement Oncology Canada REI: Advisory Group for Patient-Reported Outcome Implementation in Vulnerable and Underserved PopulationsQuality Improvement Oncology USA Improving the quality of care of patients with urothelial cancerQuality Improvement Oncology Italy Mental Health in RheumatologyRelease Date:Quality Improvement Inflammation & Immunology Canada